BioSpace News Archive

Houston, TX - BreviTest Technologies has been awarded a $1,500,000 grant from the National Institute on Drug Abuse of the National Institutes of Health to further the commercialization of its point-of-care analyzer for rapid opioid urine testing.

The agreement revolves around the development and commercialization of Pliant’s preclinical candidate, PLN-1474, and up to three more integrin targets for liver fibrosis associated with nonalcoholic steatohepatitis.

Adocia, a clinical stage biopharmaceutical company focused on diabetes treatment and other metabolic diseases with innovative formulations of proteins and peptides, announced third quarter revenue and net cash position as of September 30, 2019.

Researchers report that both fluoride and aluminum, individually, are poisonous to the nervous system.

Kineticos Life Sciences announces the further expansion of their senior leadership team with the addition of Dan McCormick, Senior Vice President, Biopharma Practice.

eHealth’s survey also shows that prescription drug costs are the number one factor driving purchasing decisions for a third of Medicare consumers

New Research Reveals Broad-Based Anti-Inflammatory Potential of Serotonin 2A Receptor Agonists at Inaugural Scientific Meeting

Health communication program, supported by Amgen Oncology since 2009, has evolved with innovative tools, including virtual healthcare provider tool in English and Spanish

This patent will allow for the protection of a specific isolated human brown adipose tissue stem cell line capable of differentiating into multiple cell types.

A new study published by authors from AMRA Medical, Linköping University and Pennington Biomedical Research Center in Journal of Gerontology: Medical Sciences on October 23, 2019 unveils a novel method for combined assessment of muscle quantity and fat infiltration to identify individuals with low functional performance using data from the UK Biobank.